What is the impact of the COVID-19 pandemic on tuberculosis?
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Although many modelling studies evaluating the impact of the COVID-19 pandemic on tuberculosis have concluded that there could potentially be thousands of extra deaths due to tuberculosis in the coming years, a recent review1 highlighted that empirical evidence on the impact of the pandemic on tuberculosis outcomes remains insufficient. The longitudinal analysis done in Indonesia by Henry Surendra and colleagues,2 published in The Lancet Global Health, has uncovered some new insights and questions on the mechanisms by which the pandemic could have affected tuberculosis outcomes within a high tuberculosis burden setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation provides some support for the hypothesis that individuals with tuberculosis and SARS-CoV-2 co-infection are more prone to dying from COVID-19 than individuals with SARS-CoV-2 infection only.97, 98”
Citations
Cites
Olsen, S. J., Azziz-Baumgartner, E., Budd, A. P., Brammer, L., Sullivan, S., Pineda, R. F., Cohen, C., & Fry, A. M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16381 · Cited by 339
The impact of COVID-19 on TB: a review of the data
McQuaid, C. F., Vassall, A., Cohen, T., Fiekert, K., COVID/TB Modelling Working Group *, & White, R. G. (2021) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0148 · Cited by 319
Barber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298
Stamm, P., Sagoschen, I., Weise, K., Plachter, B., Münzel, T., Gori, T., & Vosseler, M. (2021) · Medical Microbiology and Immunology · doi:10.1007/s00430-021-00720-7 · Cited by 82
Wang, Q., Guo, S., Wei, X., Dong, Q., Xu, N., Li, H., Zhao, J., & Sun, Q. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059396 · Cited by 61
Surendra, H., Elyazar, I., Puspaningrum, E., Darmawan, D., Pakasi, T. T., Lukitosari, E., Sulistyo, S., Deviernur, S. M., Fuady, A., Thwaites, G. E., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00312-1 · Cited by 57
Arentz, M., Ma, J., Zheng, P., Vos, T., Murray, C. J. L., & Kyu, H. H. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07078-y · Cited by 37
Self-citationAttributed causes of excess mortality during the COVID-19 pandemic in a south Indian city
Lewnard, J. A., B, C. M., Kang, G., & Laxminarayan, R. (2023) · Nature Communications · doi:10.1038/s41467-023-39322-7 · Cited by 23
Cited by
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
Self-citation
Metadata
- Authors
- Kyu, H. H., & Ledesma, J. R.
- Affiliations
- University of Washington (US)
- Corresponding author
- Kyu, Hmwe H
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 11
- Issue
- 9
- Pages
- e1323-e1324
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W4385833566
- Cited by
- 13
- References
- 8
- Citations by year
- 2025: 9 · 2024: 4
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Global Health (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- COVID-19 pandemic, tuberculosis, tuberculosis mortality, Indonesia
- MeSH terms
- COVID-19, Humans, Tuberculosis, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What is the impact of the COVID-19 pandemic on tuberculosis? https://app.cochat.ai/papers/10.1016/s2214-109x(23)00360-1
- The paper
- Kyu, H. H., & Ledesma, J. R. (2023). What is the impact of the COVID-19 pandemic on tuberculosis? The Lancet Global Health. https://doi.org/10.1016/s2214-109x(23)00360-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.